You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 142 No. 8, August 1982 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ORIGINAL INVESTIGATIONS
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (66)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Lipid Metabolism in Non-Insulin-Dependent Diabetes Mellitus

Effect of Glipizide Therapy

Michael S. Greenfield, MD; Leonard Doberne, MD; Mark Rosenthal, MD; Hendrik J. Vreman, PhD; Gerald M. Reaven, MD

Arch Intern Med. 1982;142(8):1498-1500.


Abstract



• Plasma lipid concentration and lipoprotein composition were studied before and after several months of glipizide treatment in 23 patients with non-insulin-dependent diabetes mellitus. The mean (±SEM) plasma glucose level fell 87 mg/dL, and the fall in plasma glucose concentration was correlated with a reduction in plasma triglyceride, very low-density lipoprotein triglyceride, cholesterol, and low-density lipoprotein cholesterol levels. Furthermore, there was a statistically significant increase in the plasma high-density lipoprotein cholesterol to total cholesterol ratio. Thus, improved diabetic control in patients treated with glipizide with non-insulin-dependent diabetes mellitus leads to changes in lipoprotein metabolism thought to be beneficial in terms of known cardiovascular risk factors.

(Arch Intern Med 1982;142:1498-1500)



Author Affiliations



From the Department of Medicine, Stanford University School of Medicine; and Geriatric Research, Education and Clinical Center, Veterans Administration Medical Center, Palo Alto, Calif.


Footnotes



Accepted for publication April 6, 1982.

Reprint requests to Geriatric Research, Education and Clinical Center, Room 182B, 3801 Miranda Ave, Palo Alto, CA 94304 (Dr Reaven).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Lipoprotein (a) Levels in Diabetes Mellitus: Relationship to Metabolic Control
Ramirez et al.
ANN INTERN MED 1992;117:42-47.
ABSTRACT  

Lack of Awareness and Treatment of Hyperlipidemia in Type II Diabetes in a Community Survey
Stern et al.
JAMA 1989;262:360-364.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1982 American Medical Association. All Rights Reserved.